Friday, March 20, 2026Fri, Mar 20, 2026

TrendingNews.today

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

HealthUnited States1 sourcesNeutral

Biopharma thesis starting to move away from obesity drugs, says Mizuho's Jared Holz

Jared Holz, Mizuho, joins 'Fast Money' to talk the future of the obesity drug trade on new data out of Novo Nordisk Wegovy trials.

Cnbc

via Cnbc

March 19, 2026 | 9:56 PM UTCUpdated 1h ago

Share Read original

Read the full article at Cnbc →

Biopharma thesis starting to move away from obesity drugs, says Mizuho's Jared Holz

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Comments

0 comments

Be respectful and constructive.

Loading comments...

Retired Nacogdoches coach seeks kidney donor after 5-year wait

Judge mostly denies Frederick Health motion to dismiss data breach lawsuit

Related Articles

Eledon Pharma FY25 Net Loss Widens; Tegoprubart Phase 3 Development On Track In Kidney Transplant

Unknown-2h ago-1 sources

Oil Prices Edge Higher After Drone Attack Targeting Kuwait Oil Refinery

Unknown-2h ago-2 sources

TUHU Car Inc. Reveals Fall In Full Year Profit

Unknown-2h ago-1 sources